| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $5,262,841 ) |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | D43TW012758 | Next Generation Training in HIV Research: Immunity in the First 1000 days in mother-infant dyads (TIGRIS) | 000 | 2 | NIH | 12/11/2024 | $185,734 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R01MH131480 | The changing face of HIV in the era of COVID-19: Maximising HIV incidence reduction through dynamic targeting of current and future distributions of acquisition risk. | 000 | 3 | NIH | 1/23/2025 | $441,781 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | UM1AI069521 | Stellenbosch University Clinical Trials Unit | 000 | 19 | NIH | 11/18/2024 | $200,500 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | UM1AI069521 | Stellenbosch University Clinical Trials Unit | 000 | 19 | NIH | 11/18/2024 | $547,252 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | UM1AI069521 | Stellenbosch University Clinical Trials Unit | 001 | 19 | NIH | 7/14/2025 | $200,499 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | UM1AI069521 | Stellenbosch University Clinical Trials Unit | 001 | 19 | NIH | 7/14/2025 | $547,251 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | K43TW012591 | Development of a Next-generation Rapid Phenotypic Assay for Drug-Resistant M. tuberculosis | 000 | 3 | NIH | 7/15/2025 | $106,193 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | D43TW012467 | African Tuberculosis Bioinformatics Training Program | 000 | 2 | NIH | 7/28/2025 | $197,020 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | D43TW012467 | African Tuberculosis Bioinformatics Training Program | 000 | 2 | NIH | 7/28/2025 | $50,000 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R33HD103093 | CHERISH (Children HIV Exposed Uninfected Research to Inform Survival and Health) | 001 | 5 | NIH | 8/11/2025 | $204,347 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R33HD103093 | CHERISH (Children HIV Exposed Uninfected Research to Inform Survival and Health) | 000 | 5 | NIH | 8/1/2025 | $299,266 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R01MH133488 | Harnessing male peer networks to enhance engagement with HIV prevention: A largescale cluster randomized trial to increase HIV self-testing and PrEP uptake | 001 | 3 | NIH | 9/25/2025 | $112,815 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R01MH133488 | Harnessing male peer networks to enhance engagement with HIV prevention: A largescale cluster randomized trial to increase HIV self-testing and PrEP uptake | 000 | 3 | NIH | 9/23/2025 | $201,486 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R01MH133488 | Harnessing male peer networks to enhance engagement with HIV prevention: A largescale cluster randomized trial to increase HIV self-testing and PrEP uptake | 002 | 3 | NIH | 9/26/2025 | $156,258 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R01HD107063 | Understanding ischemia in children with tuberculous meningitis (iThemba) | 001 | 4 | NIH | 8/19/2025 | $204,288 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R01HD107063 | Understanding ischemia in children with tuberculous meningitis (iThemba) | 000 | 4 | NIH | 7/28/2025 | $166,455 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R01AI175235 | Identifying correlates of risk for future tuberculosis disease progression in children (INTREPID) | 000 | 3 | NIH | 9/19/2025 | $250,000 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R01AI175235 | Identifying correlates of risk for future tuberculosis disease progression in children (INTREPID) | 002 | 3 | NIH | 9/24/2025 | $28,397 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R01AI175235 | Identifying correlates of risk for future tuberculosis disease progression in children (INTREPID) | 001 | 3 | NIH | 9/23/2025 | $255,081 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R01AI175235 | Identifying correlates of risk for future tuberculosis disease progression in children (INTREPID) | 000 | 3 | NIH | 9/19/2025 | $259,750 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | K43TW012302 | Longitudinal microbiome-host interactions and clinical outcomes in drug-resistant tuberculosis patients | 001 | 4 | NIH | 7/15/2025 | $89,253 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | D43TW010547 | Africa Center for Biostatistical Excellence: Expanding biostatistical leadership for HIV/AIDS and TB Research | 000 | 9 | NIH | 7/9/2025 | $246,960 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | D43TW010547 | Africa Center for Biostatistical Excellence: Expanding biostatistical leadership for HIV/AIDS and TB Research | 000 | 9 | NIH | 7/9/2025 | $50,000 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | D43TW010547 | Africa Center for Biostatistical Excellence: Expanding biostatistical leadership for HIV/AIDS and TB Research | 001 | 9 | NIH | 7/31/2025 | $0 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | D43TW010547 | Africa Center for Biostatistical Excellence: Expanding biostatistical leadership for HIV/AIDS and TB Research | 001 | 9 | NIH | 7/31/2025 | $0 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | K43TW012577 | A comprehensive whole genome sequence scan for positive selection in southern Africa | 000 | 3 | NIH | 7/14/2025 | $1 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | K43TW012577 | A comprehensive whole genome sequence scan for positive selection in southern Africa | 000 | 3 | NIH | 7/14/2025 | $101,133 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | U01AI152075 | Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb) | 001 | 5 | NIH | 8/21/2025 | $1,059,114 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | K43TW012786 | Mycobacterial Epigenetics: Investigating the impact of DNA methylation on antibiotic tolerance and persistence | 000 | 2 | NIH | 9/7/2025 | $107,014 |
| | 2025 | 2025 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | D43TW012758 | Next Generation Training in HIV Research: Immunity in the First 1000 days in mother-infant dyads (TIGRIS) | 000 | 2 | NIH | 12/11/2024 | $116,666 |
| | 2025 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | K43TW012849 | Cardiovascular magnetic resonance assessment of subclinicalcardiovascular abnormalities before and after the initiation of antiretroviral therapy in HIV-infected South Africans | 000 | 1 | NIH | 8/22/2025 | -$100,558 |
| | 2025 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | U01MH127704 | Research for Ethical Data Science in Southern Africa (REDSSA) | 000 | 4 | NIH | 9/8/2025 | $0 |
| | 2025 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | U01MH127704 | Research for Ethical Data Science in Southern Africa (REDSSA) | 001 | 4 | NIH | 9/18/2025 | -$674,197 |
| | 2025 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | K43TW012302 | Longitudinal microbiome-host interactions and clinical outcomes in drug-resistant tuberculosis patients | 000 | 3 | NIH | 7/14/2025 | $0 |
| | 2025 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R01AI136837 | Adaptation, fitness and resistance in rifampicin-resistant M. tuberculosis | 000 | 5 | NIH | 8/26/2025 | -$96,198 |
| | 2025 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | K43TW011028 | The long-term consequences of pulmonary tuberculosis and respiratory viruses on lung health in young South African children | 000 | 5 | NIH | 8/6/2025 | $0 |
| | 2025 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R21TW012384 | Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke | 000 | 2 | NIH | 7/21/2025 | $0 |
| | 2025 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R21TW012384 | Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke | 000 | 2 | NIH | 7/21/2025 | $0 |
| | 2025 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | U01AI152075 | Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb) | 000 | 4 | NIH | 10/11/2024 | $0 |
| | 2025 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | K43TW012849 | Cardiovascular magnetic resonance assessment of subclinicalcardiovascular abnormalities before and after the initiation of antiretroviral therapy in HIV-infected South Africans | 000 | 1 | NIH | 8/22/2025 | -$1 |
| | 2025 | 2023 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | D71TW012265 | Next generation training in HIV research: Immunity in the First 1000 days in mother-infant dyads (TIGRIS) | 000 | 2 | NIH | 6/4/2025 | $0 |
| | 2025 | 2022 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R01AI136836 | Inhibitors of CoA biosynthesis as novel antitubercular and antistaphylococcal agents | 000 | 5 | NIH | 4/23/2025 | $0 |
| | 2025 | 2022 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R21TW012185 | Study of Metformin to reduce Cerebrovascular Dysfunction in South African patients with HIV and Metabolic Syndrome: A Phase II Pilot Trial. SMART | 000 | 2 | NIH | 10/28/2024 | $0 |
| | 2025 | 2021 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | D43TW010511 | Advancing Research Ethics Training in Southern Africa (ARESA): Leadership Program | 000 | 5 | NIH | 9/29/2025 | -$250,719 |
|
| Issue Date FY: 2024 ( Subtotal = $8,642,868 ) (Continued on the next page) |
| | 2024 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | K43TW012577 | A comprehensive whole genome sequence scan for positive selection in southern Africa | 001 | 2 | NIH | 4/24/2024 | $1 |
| | 2024 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | U01MH127704 | Research for Ethical Data Science in Southern Africa (REDSSA) | 000 | 4 | NIH | 8/12/2024 | $376,418 |
| | 2024 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | K43TW012849 | Cardiovascular magnetic resonance assessment of subclinicalcardiovascular abnormalities before and after the initiation of antiretroviral therapy in HIV-infected South Africans | 001 | 1 | NIH | 9/20/2024 | -$100,558 |
| | 2024 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | K43TW012849 | Cardiovascular magnetic resonance assessment of subclinicalcardiovascular abnormalities before and after the initiation of antiretroviral therapy in HIV-infected South Africans | 000 | 1 | NIH | 9/2/2024 | $1 |
|
